scholarly journals The sexual lives of breast cancer patients: Coping with changes associated with treatment

2017 ◽  
Vol 6 (1) ◽  
pp. 61
Author(s):  
Ayumi Yoshikawa ◽  
Shinya Saito ◽  
Makiko Kondo ◽  
Yuko Tsuyumu ◽  
Naruto Taira ◽  
...  

Objective: To clarify how breast cancer patients undergoing post-surgical hormone therapy cope with changes in their sexual lives and support themselves and their partners during these changes.Methods: Participants were 37 breast cancer patients undergoing post-surgical hormone therapy and attending mammary outpatient clinics. In-depth interviews and grounded theory were used to collect and analyze data, respectively.Results: First, sexual life was divided into four groups: “No complaint” regarding sexual activity, “Slight discord”, “Handicapped in meeting a life partner” and “Uninterested” in sexual activity. Sexual life during surgical-hormone therapy did not change significantly from sexual life before breast cancer. Second, meanings of sexual activity for breast cancer patients were divided into five, “Regaining femininity”, “Confirming love”, “Sharing pleasure”, “Response to partner’s higher desire” and “Procreation”. They differed by group. Third, coping strategies were divided into six, “Virtuous cycle to confirm love and regain lost femininity”, “Struggle to avoid relationship crisis”, “Reconfirmation of partner’s affection by his abstinence”, “Attempt to recover the sexual activity they hope for”, “Pursuing children or assuaging partner’s desire by other means” and “Difficulty making a partner continue to have sexual activity”.Conclusions: Nurses should screen breast cancer patients for changes in their sexual lives and to ascertain what sexual activity means to patients, and support them in selecting appropriate coping methods.

2020 ◽  
Author(s):  
Edgar Muñoz ◽  
Cliff Despres ◽  
Pramod Sukumaran ◽  
Illeana Tiemann ◽  
Bianca Gutierrez ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 11514-11514
Author(s):  
A. Jain ◽  
P. Bapsy ◽  
S. V. Attili ◽  
U. Batra ◽  
L. Dasappa ◽  
...  

11514 Background: Hormone receptor positive patents historically had a better prognosis than their receptor negative counterparts when other parameters are balanced. However not all the patients expressing Estrogen and progesterone respond well to the hormonal manipulation. Therefore we thought of doing a retrospective analysis of our hospital data to find out the differences in the prognostic factors in therapy responders and non responders. Methods: The study was conducted at tertiary care cancer center from India. Between 2002–2003 a total of 120 breast cancer patients who expressed either Estrogen receptor (ER) or progesterone receptor (PR) were analyzed. Only patients with metastatic breast cancer were analyzed. The patients were treated with our standard institutional protocol at the beginning according to the stage of the disease. The details and baseline characters were shown in table . Results: The responders tend to be post menopausal, having low grade, node negative tumors, expressed both ER and PR, and had long interval from the date of initial diagnosis. However tumor size and the site of metastasis (visceral vs. non visceral) did not alter the outcome to hormone therapy. Conclusion: patients who are having higher age, lower tumor grade, lower number of nodes, longer disease free interval after adjuvant therapy and expressing both receptors tend to respond to hormone therapy better than those who had the opposite characters. However as thought earlier, presence of visceral metastasis or larger tumors at the time of initial diagnosis dose not preclude response to hormonal manipulation. [Table: see text] No significant financial relationships to disclose.


2010 ◽  
Vol 73 (1) ◽  
pp. 92-98 ◽  
Author(s):  
Diana Crivellari ◽  
Simon Spazzapan ◽  
Fabio Puglisi ◽  
Lucia Fratino ◽  
Simona Scalone ◽  
...  

Surgery Today ◽  
2013 ◽  
Vol 44 (10) ◽  
pp. 1841-1846 ◽  
Author(s):  
Kenji Taketani ◽  
Eriko Tokunaga ◽  
Nami Yamashita ◽  
Kimihiro Tanaka ◽  
Sayuri Akiyoshi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document